Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

CNSide Diagnostics

Tracked across 1 events · 6 articles · First seen Sep 10, 2026 · Last active Sep 13, 2026

Sentiment
20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Cerenome, Inc. (Nasdaq: CNSY), a clinical-stage CNS oncology company, announced on September 10, 2026 that it entered into a financing agreement with 3i, LP for a senior secured facility of up to $20 million with…
Impact: CNSide Diagnostics, the wholly owned Cerenome subsidiary, is the primary beneficiary of the financing as proceeds support scale-up of its CNSide cerebrospinal fluid assay platform.
Sep 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track CNSide Diagnostics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.